Bacitracin and Dermabond Should Not Be Used Together
Bacitracin (topical antibiotic) and Dermabond (2-octyl cyanoacrylate) should not be used together due to potential incompatibility and risk of allergic contact dermatitis. 1
Rationale for Avoiding This Combination
- The American Contact Dermatitis Society specifically lists "application of known allergens" including "products containing topical antibiotics (eg, neomycin, bacitracin)" and "applications of superglue (ethyl cyanoacrylate)" as risk factors for inducing or worsening hand allergic contact dermatitis 1
- Bacitracin is known to be a common allergen that can cause sensitization and treatment failure when used topically 2
- Dermabond (2-octyl cyanoacrylate) has its own intrinsic antimicrobial properties against Gram-positive bacteria, making additional topical antibiotics like bacitracin redundant 3
Antimicrobial Properties of Dermabond
- Dermabond demonstrates bactericidal properties against Gram-positive bacteria, which may help reduce postoperative wound infection without requiring additional topical antibiotics 3
- The tissue adhesive forms a strong bond across apposed wound edges, creating a flexible water-resistant protective coating that allows normal healing to occur beneath it 4
- This protective barrier function of Dermabond helps prevent bacterial access to the wound, providing physical protection in addition to its intrinsic antimicrobial properties 3, 4
Concerns with Bacitracin Use
- Topical use of bacitracin may produce treatment failure and sensitization 2
- Bacitracin is specifically listed as a medication that should be avoided in combination with other agents due to its allergenic potential 1
- The American Contact Dermatitis Society warns against "occluding fingers with adhesive bandage impregnated with bacitracin or benzalkonium chloride" due to increased risk of dermatitis 1
Successful Alternatives
- Clinical studies have shown that Dermabond can be used effectively without topical antibiotics for wound closure 5
- A study of cardiac device implant wound closure found that using 2-octyl cyanoacrylate (Dermabond) "obviated the need for topical antibiotics" with no increase in infection rates compared to traditional closure methods with bacitracin 6
- When Dermabond was used with Tegaderm (without antibiotics), researchers found reduced wound infection rates, increased patient comfort, and proper wound healing 5
Best Practice Recommendations
- Use Dermabond alone for appropriate wound closure, taking advantage of its inherent antimicrobial properties and barrier function 3, 4
- If antimicrobial coverage is a concern, consider that Dermabond itself has demonstrated bactericidal effects against Gram-positive bacteria 3
- For wounds requiring additional antimicrobial protection, consider alternative wound care approaches that don't combine potentially incompatible agents 5, 6
- Avoid applying bacitracin before or after Dermabond application, as this combination is specifically listed as problematic by dermatology guidelines 1
By avoiding the combination of bacitracin and Dermabond, you can reduce the risk of contact dermatitis while still achieving effective wound closure and appropriate antimicrobial protection.